Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Brief Psychotic Disorder
- Sponsor
- Fundació Sant Joan de Déu
- Enrollment
- 70
- Primary Endpoint
- PANSS. Positive and Negative Syndrome Scale. (Kay et al., 1987; Peralta and Cuesta, 1994)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. Secondary aims would be to assess the effect of EMC+ in metacognition, psychosocial and neuropsychological functioning, and to assess the maintenance of program effects on 6 months.
Detailed Description
This is a randomized clinical trial in which some patients receive the EMC+ and others treatment as usual.The evaluator will be blind to the group to which the patients belong. The sample for the overall project will be a total of 70 people with a diagnosis of psychotic spectrum, less than 5 years of experience and with a score =\> 3 positive PANSS (last month) and treated in one of the participating institutions. The evaluation was performed at baseline, at post-treatment and at 6 months follow up. Symptoms, metacognition, psychosocial and neuropsychological functioning were assessed. The EMC consists of 10 therapeutic units with weekly sessions of 45-60 minutes. The material available for the Individualized Metacognitive Training (EMC) program is made up of power-point presentations.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of : schizophrenia, schizoaffective disorder, brief psychotic disorder, delusional disorder, schizophreniform disorder, psychotic disorder not otherwise specified.
- •Less than 5 years of evolution.
- •Score at or above 4 on the PANSS during the last year (delusions, grandiosity, suspiciousness).
Exclusion Criteria
- •Traumatic brain injury, dementia, or intellectual disability (premorbid IQ ≤70).
- •Substance dependence.
- •Score at or above 5 on the PANSS ( Hostility and Uncooperativeness); score at or above 6 on the PANSS (suspiciousness).
Outcomes
Primary Outcomes
PANSS. Positive and Negative Syndrome Scale. (Kay et al., 1987; Peralta and Cuesta, 1994)
Time Frame: 6 months follow-up
The Positive and Negative Syndrome Scale (PANSS). This scale measures 30 symptoms on a scale of 1-7, with higher scores indicating greater psychopathology. The PANSS contains three sub-scales: positive, negative and general symptoms.Range: 7-112. Higher values represent a worse outcome.
Secondary Outcomes
- BCIS. Beck Cognitive and Insight Scale. (Beck et al., 2004; Gutierrez-Zotes et al., 2012)(6 months follow-up)
- The Hinting Task. (Corcoran et al. 1995; Gil et al. 2012)(6 months follow-up)
- Emotional Recognition Test Faces. (Baron-Cohen et al. 1997)(6 months follow-up)
- MASC. (Lahera et al.2014).(immediately after the intervention)
- Jumping to conclusions. (Brett-Jones et al. 1987).(6 months follow-up)
- IPSAQ. Internal, Personal and Situational Attribution Questionnaire. (Kinderman & Bentall, 1996)(6 months follow-up)